These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6292712)

  • 21. In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
    Hernández Molina JM; Llosá J; Martinez Brocal A; Ventosa A
    Mycopathologia; 1992 Apr; 118(1):15-21. PubMed ID: 1406898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In-vitro resistance to imidazole antifungals in Candida albicans.
    Johnson EM; Richardson MD; Warnock DW
    J Antimicrob Chemother; 1984 Jun; 13(6):547-58. PubMed ID: 6381460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of two polyene and two imidazole antimicrobics on Candida albicans in human fibrin clots.
    Smith BM; Hoeprich PD; Huston AC; Schaffner CP; Franti CE
    J Lab Clin Med; 1983 Jul; 102(1):126-32. PubMed ID: 6304213
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct membrane-damaging effect of ketoconazole and tioconazole on Candida albicans demonstrated by bioluminescent assay of ATP.
    Anséhn S; Nilsson L
    Antimicrob Agents Chemother; 1984 Jul; 26(1):22-5. PubMed ID: 6089651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of ketoconazole on isolated mitochondria from Candida albicans.
    Shigematsu ML; Uno J; Arai T
    Antimicrob Agents Chemother; 1982 Jun; 21(6):919-24. PubMed ID: 6287930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketoconazole resistance.
    Lancet; 1982 Oct; 2(8301):770-1. PubMed ID: 6125840
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
    Van 't Wout JW; Meynaar I; Linde I; Poell R; Mattie H; Van Furth R
    J Antimicrob Chemother; 1990 May; 25(5):803-11. PubMed ID: 2165051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of ketoconazole and its deacyl derivative against Plasmodium falciparum and Candida isolates.
    Pfaller MA; Segal JJ; Krogstad DJ
    Antimicrob Agents Chemother; 1982 Nov; 22(5):917-9. PubMed ID: 6295271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary site of action of ketoconazole on Candida albicans.
    Uno J; Shigematsu ML; Arai T
    Antimicrob Agents Chemother; 1982 Jun; 21(6):912-8. PubMed ID: 6287929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics.
    Brajtburg J; Kobayashi D; Medoff G; Kobayashi GS
    J Infect Dis; 1982 Aug; 146(2):138-46. PubMed ID: 6286784
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
    La Regina G; D'Auria FD; Tafi A; Piscitelli F; Olla S; Caporuscio F; Nencioni L; Cirilli R; La Torre F; De Melo NR; Kelly SL; Lamb DC; Artico M; Botta M; Palamara AT; Silvestri R
    J Med Chem; 2008 Jul; 51(13):3841-55. PubMed ID: 18529046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
    Odds FC; Cockayne A; Hayward J; Abbott AB
    J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).
    Zida A; Yacouba A; Bamba S; Sangare I; Sawadogo M; Guiguemde T; Kone S; Traore LK; Ouedraogo-Traore R; Guiguemde RT
    J Mycol Med; 2017 Dec; 27(4):469-475. PubMed ID: 28754462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections.
    Odds FC; Webster CE
    J Antimicrob Chemother; 1988 Oct; 22(4):473-81. PubMed ID: 2849601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of (E)-1-(5-chlorothien-2-yl)-2-(1H-imidazol-1-yl)ethanone 2,6-dichlorophenylhydrazone hydrochloride, a novel, orally active antifungal agent.
    Dyer RL; Ellames GJ; Hamill BJ; Manley PW; Pope AM
    J Med Chem; 1983 Mar; 26(3):442-5. PubMed ID: 6298430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of sterol biosynthesis in Candida albicans by imidazole-containing antifungals.
    Marriott MS
    J Gen Microbiol; 1980 Mar; 117(1):253-5. PubMed ID: 6993625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanism of action of the new antimycotic ketoconazole.
    Borgers M; Van den Bossche H; De Brabander M
    Am J Med; 1983 Jan; 74(1B):2-8. PubMed ID: 6295147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro antifungal activity of saperconazole (R 66905) against Candida and Torulopsis.
    Mallié M; Montès B; Lebecq JC; Bastide JM
    Mycoses; 1989 Dec; 32(12):631-7. PubMed ID: 2695841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytological study of the action of imidazoles on Candida albicans (author's transl)].
    Bastide M; Jouvert S; Bastide JM
    Pathol Biol (Paris); 1982 Jun; 30(6):458-62. PubMed ID: 7050853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Propyl gallate increases in vitro antifungal imidazole activity against Candida albicans.
    Strippoli V; Dauria FD; Tecca M; Callari A; Simonetti G
    Int J Antimicrob Agents; 2000 Sep; 16(1):73-6. PubMed ID: 11185418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.